Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Phase Forward, a provider of data management solutions for clinical trials and drug safety, has signed a multi-year, multi-million dollar enterprise licensing and services agreement with Danish healthcare company Novo Nordisk, expanding the existing relationship between the two companies.
Subscribe to our email newsletter
Novo Nordisk plans to use Phase Forward’s InForm electronic data capture product as the default data capture system across all clinical trial phases, from Phases I through IV.
Since signing an application service provider arrangement in mid-2006, Novo Nordisk has successfully implemented and integrated global InForm studies with internal systems. Novo Nordisk is currently using InForm to support trials in more than 30 countries.
Henrik Lynge, head of clinical system management at Novo Nordisk, said: “We’ve had a very successful collaboration with Phase Forward over the last three years, and look forward to expanding the relationship. InForm’s ability to easily integrate with other in-house systems and the product’s scalability have been crucial to the implementation, enabling our team to streamline data collection for complex studies spanning multiple geographies.”